Labroots

IVDR: where are we now in molecular testing?

IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
Medscape

Molecular Testing in Dermatology: Who and When to Test

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

Genomic Testing Cooperative Highlights Expanded Role of CSF-Based Molecular Profiling Following NCCN Update

Genomic Testing Cooperative (GTC) today highlighted its Liquid Trace® cerebrospinal fluid (CSF)-based molecular profiling ...
Nasdaq

Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Nature

Implementation of large-scale pooled testing to increase rapid molecular diagnostic test coverage for tuberculosis: a retrospective evaluation

In 2021, only 6.4 million of the 10.6 million people with tuberculosis (TB) were diagnosed and treated for the disease. Although the World Health Organization recommends initial diagnostic testing ...
Labroots

Streamlining Respiratory Virus Testing with Molecular Diagnostics: Impact on patients and laboratory

Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...
Healio

Comprehensive molecular testing in lung cancer ‘absolutely crucial’ yet underutilized

Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...
Hosted on MSN

Insight Molecular Diagnostics outlines $1B transplant testing market expansion as company nears FDA submission

Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with ...
Nature

High capacity clinical SARS-CoV-2 molecular testing using combinatorial pooling

The SARS-CoV-2 pandemic led to unprecedented testing demands, causing major testing delays globally. One strategy used for increasing testing capacity was pooled-testing, using a two-stage technique ...
The American Journal of Managed Care

Gaps in Molecular Testing Rates, Targeted Treatment Persist in MDS, AML

Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...

Bloodstream Infection Testing Market Size to Reach USD 1,404.68 Million by 2035 | SNS Insider

The U.S. Bloodstream Infection Testing Market is projected to grow from USD 221.68 Million in 2025 to USD 355.49 Million by ...